Serina Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Serina Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2020 to Q3 2024.
  • Serina Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 74.2 %, a 569% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 74.2 +63.1 +569% Sep 30, 2024
Q2 2024 85 +74.8 +732% Jun 30, 2024
Q1 2024 44.1 +30 +213% Mar 31, 2024
Q4 2023 23 +4.06 +21.5% Dec 31, 2023
Q3 2023 11.1 -7.78 -41.2% Sep 30, 2023
Q2 2023 10.2 -10.7 -51.1% Jun 30, 2023
Q1 2023 14.1 -8.85 -38.6% Mar 31, 2023
Q4 2022 18.9 -11 -36.8% Dec 31, 2022
Q3 2022 18.9 -16.4 -46.4% Sep 30, 2022
Q2 2022 20.9 -19.9 -48.7% Jun 30, 2022
Q1 2022 22.9 -21.9 -48.9% Mar 31, 2022
Q4 2021 29.9 -11.2 -27.3% Dec 31, 2021
Q3 2021 35.2 -20.2 -36.4% Sep 30, 2021
Q2 2021 40.8 -38.1 -48.3% Jun 30, 2021
Q1 2021 44.9 -77.5 -63.3% Mar 31, 2021
Q4 2020 41.1 Dec 31, 2020
Q3 2020 55.4 Sep 30, 2020
Q2 2020 78.9 Jun 30, 2020
Q1 2020 122 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.